Fortitude Re's $3.8B Deal Moves 26% of Unum's LTC Risk Off Balance

Unum ceded $3.8 billion of individual long-term care statutory reserves to Fortitude Re on July 6, 2026, its second cession to the same reinsurer in 17 months. The block covers roughly 50,000 policies and 26% of total LTC reserves, and leaves the group book untouched.

Two numbers inside the release do more work than the headline: the ceded reserves carry $4.5 billion of best-estimate liability, and Fortitude Re is retroceding 100% of the risk to a party neither company names.

Key Takeaways

• $3.8 billion of statutory reserves against $4.5 billion of best-estimate reserves, a $700 million gap on the same block, is the distance the statutory basis sits below a current view of ultimate cost.
• 52% of individual LTC reserves ceded against 26% of the combined total, which moves the remaining $11.0 billion book to roughly 70% group.
• Roughly 40% of Unum's LTC statutory reserves gone in 17 months across two Fortitude Re deals, the first $3.4 billion on July 1, 2025 for about $100 million of capital benefit.
• 100% of the assumed risk is retroceded to an unnamed "highly rated global reinsurance partner," the same structure used in the February 2025 transaction.
• Unum keeps the customer. Claims handling, rate-increase program administration and servicing stay in-house while the economics move to Bermuda.

A Second Cession in 17 Months

Unum will recapture an individual LTC block from its subsidiary Fairwind Insurance Company and cede it to Fortitude Re, moving $3.8 billion of statutory reserves and about $4.5 billion of best-estimate reserves on roughly 50,000 policies. The block is 26% of total LTC reserves and 52% of individual LTC reserves as of March 31, 2026, taking remaining statutory LTC reserves to approximately $11.0 billion, about 70% of it group business.

"This marks another important step in advancing our Closed Block strategy to further reduce exposure to legacy long-term care business," said Richard P. McKenney, Unum's president and CEO. The deal is expected to close during 2026 subject to regulatory approval, funded from Fairwind's excess capital, holding-company liquidity and financing tied to future tax benefits. Unum projects year-end holding-company liquidity of $1.5 billion to $2.0 billion, leverage near 25% and an RBC ratio of 400% to 425%.

The disclosed percentages let the mix be reconstructed. If $3.8 billion is 52% of the individual book, that book stood near $7.3 billion beforehand; if the same amount is 26% of the combined total, the combined book was close to $14.6 billion, an approximately even split. Afterward individual falls to about $3.5 billion against group near $7.3 billion, which is the 30/70 shape Unum disclosed.

Unum did not shrink LTC exposure by a quarter. It rebalanced away from the half of the portfolio that has been hardest to price for thirty years.

The $700 Million Gap Is the Selection Logic

Statutory reserves for individual LTC run on a net level premium method built from the lapse, morbidity and interest assumptions locked at issue. Those assumptions are the problem the whole market has been working through: policies written in the 1980s and 1990s priced lapse at roughly 4% to 5% a year against actual experience nearer 1%, on morbidity tables that understated both claim incidence and duration.

A best-estimate reserve running $700 million above the statutory figure on the same block is that pattern measured. The formula basis, still anchored to issue-date assumptions, sits below what an actuary expects the business to pay. For a carrier holding a comparable block, that gap is the number that decides between another rate filing and a transaction: carriers requested a 56% average increase nationwide and states approved 28% of it, through a process averaging six months per state.

That arithmetic also explains why the group book stayed. Individual LTC is guaranteed renewable, carries decades of underwriting vintage inside its original pricing, and can only be repriced through state approval. Group LTC is employer-sponsored, repriced closer to a group health renewal cycle, carries less anti-selection because enrollment runs through a workplace population, and turns over as sponsors switch or drop the benefit.

Other carriers have split on the same arithmetic. Manulife ceded C$6.0 billion of in-force LTC to Global Atlantic at the end of 2023 and followed with a $2.4 billion 75% quota share to RGA in November 2024, cumulatively cutting LTC reserves 18% and LTC morbidity sensitivity 17%. Genworth has taken the other path, reporting an estimated $31.2 billion of cumulative economic benefit on a net present value basis from approved increases and benefit reductions between 2012 and 2024. Both are defensible answers to the same gap.

Three Layers Between the Policyholder and the Payer

Fortitude Re is not retaining what it is assuming. It will retrocede 100% of the LTC risk to a party described only as a highly rated global reinsurance partner, mirroring the February 2025 transaction, where biometric risk likewise went to an unnamed reinsurer. Fortitude Re's disclosed role is the spread-based asset management side, backed by its relationship with Carlyle Group.

For the original policyholder the chain now runs three deep: a primary insurer that handles claims but holds no economic risk, a Bermuda reinsurer that structures the deal and manages the assets, and an undisclosed retrocessionaire that stands behind the eventual payments.

That has a direct consequence for the ceding actuary's asset adequacy testing. Assessing recoverability against a named, rated counterparty is one exercise; forming a view on collectability when the ultimate obligor is not public is a materially different one, and the reinsurance recoverable is a large asset on a long-duration liability.

It also limits what regulators can see. If Fortitude Re and the other reinsurers active in LTC are retroceding into a smaller set of ultimate capacity providers than the count of announced transactions implies, the market's real counterparty concentration is higher than the deal list shows. Working back from the disclosed shares, Unum has moved more than $7 billion off its own balance sheet in 17 months, from a book near $17.9 billion before the first deal. Where that risk finally sits is the part of the transaction nobody has published.